Over the past two decades, one of the most exciting breakthroughs in biomedical research was the discovery of anti-retroviral therapy (ART), which curbs active HIV replication to nearly undetectable levels. Despite this great achievement, ART fails to cure HIV infection because latent reservoirs persist in tissues containing resting CD4 lymphocytes and other cell types that express low levels of viral products and can be reactivated in response to immune stimulation. Thus, these latent reservoirs are a critical barrier for a functional cure, making the need for new approaches even more urgent. To achieve this major goal, we must first identify novel, critical host factors that can be targeted therapeutically before we can leverage this knowledge for clinical intervention. To this end, this proposal will investigate a master host factor (KAP1) implicated in transducing a variety of physiologic immune signal inputs into proviral transcriptional outputs to reveal the molecular mechanisms and evaluate therapeutic potential. Our work is different from previous studies because it will help uncouple the contribution of the three major features influencing proviral transcription and fate (complex transcriptional circuit architecture, integration landscape, and immune cell state) to help devise rationale approaches for HIV eradication. We hypothesize that both the integration landscape and immune cell state regulate the outcome of an infection (active, latent, reactivated) through the function of critical master host factors like KAP1. New technologies and experimental approaches for investigating this problem provide unique opportunities to test this hypothesis and define the underlying molecular mechanisms. Specifically, we will investigate: 1) how KAP1 communicates with other host co-factors to assemble a positive transcription complex to promote the latency-reactivation switch in response to immune stimulation, 2) how the integration landscape and cell state influence KAP1-mediated proviral transcription activation and clonal expansion, 3) how KAP1 recognizes proviral chromatin to function as a ?scaffold? to couple transcription initiation and elongation, and 4) how KAP1 enzymatic functions help relieve the repression imparted by novel transcriptional co-repressors assembled at the provirus during the latency-reactivation switch. The knowledge generated in this study will establish the groundwork for interfering with the function of various ?druggable pockets? (e.g., enzymatic and chromatin reader domains) for HIV eradication strategies. The combination of high significance, innovation and use of a diverse set of experimental approaches in physiologically relevant systems (primary models of latency and patient samples) make this proposal unique. Collectively, these studies could have a revolutionary impact on our understanding of HIV latency biology and have therapeutic implications.

Public Health Relevance

Despite effective anti-retroviral therapy in HIV-infected patients, proviruses persist in a transcriptionally silent, latent state in resting lymphocytes and cells from the central nervous system. Identifying the most effective and selective therapeutic routes to eliminate the latent reservoir requires a comprehensive understanding of the molecular rules normally controlling proviral transcription and how their dysfunction promotes latency establishment and maintenance. In this proposal, we will investigate a previously unexplored host co-factor that is critical for promoting the latency-reactivation switch in response to physiologic immune cell signaling to devise rationale approaches for targeting unique druggable pockets to translate the basic discoveries for pre- clinical applications.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Research Project (R01)
Project #
Application #
Study Section
HIV Molecular Virology, Cell Biology, and Drug Development Study Section (HVCD)
Program Officer
Lawrence, Diane M
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Texas Sw Medical Center Dallas
Schools of Medicine
United States
Zip Code
Faust, Tyler B; Li, Yang; Bacon, Curtis W et al. (2018) The HIV-1 Tat protein recruits a ubiquitin ligase to reorganize the 7SK snRNP for transcriptional activation. Elife 7:
Bacon, Curtis W; D'Orso, Iván (2018) CDK9: a signaling hub for transcriptional control. Transcription :1-19
Guzman, Carlos; D'Orso, Iván (2017) CIPHER: a flexible and extensive workflow platform for integrative next-generation sequencing data analysis and genomic regulatory element prediction. BMC Bioinformatics 18:363
Ma, Zheng; Fung, Victor; D'Orso, Iván (2017) Tandem Affinity Purification of Protein Complexes from Eukaryotic Cells. J Vis Exp :
D'Orso, Iván (2016) 7SKiing on chromatin: Move globally, act locally. RNA Biol 13:545-53
McNamara, Ryan P; Bacon, Curtis W; D'Orso, Iván (2016) Transcription elongation control by the 7SK snRNP complex: Releasing the pause. Cell Cycle 15:2115-2123
McNamara, Ryan P; Guzman, Carlos; Reeder, Jonathan E et al. (2016) Genome-wide analysis of KAP1, the 7SK snRNP complex, and RNA polymerase II. Genom Data 7:250-5
Gudipaty, Swapna Aravind; D'Orso, Iván (2016) Functional interplay between PPM1G and the transcription elongation machinery. RNA Dis 3:
McNamara, Ryan P; Reeder, Jonathan E; McMillan, Elizabeth A et al. (2016) KAP1 Recruitment of the 7SK snRNP Complex to Promoters Enables Transcription Elongation by RNA Polymerase II. Mol Cell 61:39-53
Gudipaty, Swapna Aravind; McNamara, Ryan P; Morton, Emily L et al. (2015) PPM1G Binds 7SK RNA and Hexim1 To Block P-TEFb Assembly into the 7SK snRNP and Sustain Transcription Elongation. Mol Cell Biol 35:3810-28

Showing the most recent 10 out of 11 publications